rthm_health

AI is powerful when it’s built with your privacy in mind. RTHM’s new intelligence platform keeps your data encrypted and HIPAA compliant, made for patients, not ad networks or AI models. Eliana highlights what matters most in keeping patient data safe. #AD #DataPrivacy #MECFS #LongCOVID #AIforGood

In August, our team went to the Keystone Conference on Long COVID in Santa Fe, and our Medical Director, Stuart Malcolm, spoke to The Sick Times about his experience being at the 3-day conference with 170 other experts

Read the full story at The Sick Times: ow.ly/58ab50XhQag

Join us for a 90-minute conversation on how RTHM’s new HIPAA-compliant intelligence platform is transforming care for complex conditions. We’ll share the vision behind the platform, show how it works, & demonstrate how it connects your health history, symptoms, and research! ow.ly/JY7v50Xa6S1

What if you had a personal medical assistant in your pocket that could help you track your symptoms, labs & history to reveal what it all means? RTHM’s new intelligence platform uses AI to connect the dots across your health data and surface testing, diagnoses, & treatments. Try it today: rthm.com⁠

Our platform is free, HIPAA-compliant, and built for people living with infection associated chronic conditions and designed to help you find the best next steps in your care.

Start connecting the dots in your health story for free. Visit: rthm.com

Big announcement 📣

RTHM’s new HIPAA-compliant intelligence platform brings your health story into focus, pulling together records, labs, diagnoses, and symptoms to transform complex data into clarity and suggest the best next steps with your care team!

Start today (it’s free!): rthm.com

Image of ketotifen at the top 43% of patients prescribed ketotifen through RTHM Direct saw overall improvements in their symptoms. 36% of those it helped reported moderate to significant benefits Swipe to learn what improved (image of an arrow)

Top Reported Improvements Images of 4 circular percentage graphs -20% - Experienced a decrease in GI Issues -23% - Saw improved 
tolerance
of foods -23% - Had reported better sleep -31% - Saw decreased allergic symptoms All data presented is based on internal patient 
outcomes from the RTHM Direct Clinic.

What is Ketotifen? Originally used for allergies and asthma, 
Ketotifen is an oral antihistamine and mast cell stabilizer that may help calm overactive immune responses in Long COVID—supporting better sleep, fewer food reactions, and reduced post-exertional crashes (PEM/PESE). Image: Recommended Dosing Chart 1-2 mg orally 1-2 times daily

Have you tried ketotifen for Long COVID, ME/CFS, or MCAS-related symptoms?

Ketotifen works as an oral antihistamine and mast cell stabilizer—helping to calm overactive immune responses.

Explore whether compounded oral Ketotifen is right for you at: direct.rthm.com

Have you tried Low Dose Naltrexone (LDN) for Long COVID, ME/CFS, or other chronic condition symptoms?

You can explore potential treatments like LDN through RTHM Direct, or join our email list for updates on research and treatment access. Link in bio to get started or sign up.

RTHM Direct Accessible care from RTHM

If you’re wondering whether LDN could be right for your symptoms, start your health assessment today: direct.rthm.com

Before treatment, Corinne faced relentless brain fog, PEM, memory loss, and the inability to follow conversations without feeling overheated and confused. Through RTHM Direct, she gained access to LDN, which resolved most of her cognitive symptoms and shortened PEM episodes.

Dr. Jennifer Curtin, Chief Medical Officer at RTHM, recently joined host Jill Brook in an episode of The POTScast to share how RTHM's new HIPAA-compliant AI tool can transform healthcare—and why that gives her hope as both a patient and a provider.

Our team had an incredible experience at #KSLongCOVID26
@KeystoneSymp! A heartfelt thanks to the organizers, the excellent speakers, & everyone we connected with for the amazing conversations. We’ve returned home inspired, hopeful, & excited to apply much of the groundbreaking research to our work.

RTHM’s Take: This is an alarming finding that may have major medical and public health implications. This study, albeit in a small number of people, demonstrates that maternal SARS-COV2 infections during pregnancy can significantly impact the neuro-development of the child after birth. At a minimum, we should be informing prospective parents about these potential risks, and provide them with the tools and knowledge to reduce the risk of contracting SARS-CoV2 during pregnancy.This area of research is very important to continue.” — Jennifer Curtin, MD, RTHM Co-Founder

Study Author Conclusions: “This study shows the long-term impact of maternal SARS-COV-2 infection on child development.. Prenatal SARS-COV-2 infection in pregnant women is linked to developmental delays in toddlers, with cytokine and chemokine changes associated with neurodevelopmental outcomes at 24 months… Identifying specific cytokines correlating with cognitive, communication, and motor delays suggests potential biomarkers for early intervention.” (Arrow pointing right) Small Citation

Cytokines & Chemokines Correlate with Cognitive, Motor, Communication Delays Elevated interferon-gamma and tumor necrosis factor-alpha in cord blood correlated with cognitive delays. Interleukin (IL)-6, IL-8, IL-17, and IL-1β were associated with motor delays. Increased C-X-C motif chemokine ligand 10 and other cytokines were associated with communication delays. (Arrow pointing right) Small Citation

Key Findings: At 6 months 33.3% of infants exhibited cognitive delays 20% communication delays 40% motor delays At 24 months 35% of infants exhibited cognitive delays 64% communication delays 57% motor delays

Description of the Study This study aimed to evaluate the impact of maternal infection on neurodevelopment and investigate whether cytokine and chemokine profiles predict delays at 24 months. Conducted in Brazil (January 2021–March 2022), this follow-up study included 18 SARS-CoV-2 positive pregnant women at 35–37 weeks’ gestation, 15 umbilical cord blood samples, and blood samples from 15 children at 6 months and 14 at 24 months. Developmental delay was defined using the Bayley Scales of Infant and Toddler Development, Third Edition, with scores below 90 in cognitive, communication, or motor domains.

New Study: SARS-COV-2 infection in pregnant women is linked to developmental delays in toddlers (Photo of a pregnant woman with a cold/fever)

A new study finds that babies whose mothers had COVID-19 during pregnancy are at increased risk of developmental delays.

COVID-19 during pregnancy may have significant negative implications for child development.

Full study: doi.org/10.1038/s413...

POTS Practitioners: Dr. Jen Curtin on the RTHM approach to improving care for complex patients Dr. Jennifer Curtin is using the latest technologies to improve patient care and offerings.  She was a ME/CFS patient herself when she went to medical school, and now is Medical Director of the R...

🎙️Listen now—link in bio! the-potscast.castos.com/episodes/pot...

Help keep conversations like this going: standinguptopots.org/donate

In a recent episode of The POTScast, Dr. Jennifer Curtin, Chief Medical Officer at RTHM Clinic, joins host Jill Brook to share how RTHM is reimagining care — innovating with telehealth, asynchronous medication offerings, and advanced technology like AI to reach more patients, at a lower cost.

Low Dose Naltrexone (LDN) has been a game changer for many RTHM Direct patients facing complex conditions like Long COVID, POTS, and ME/CFS.

If you're wondering whether LDN could be right for your symptoms, start your health assessment today. direct.rthm.com

The authors estimate nearly 6 million U.S. children may be affected by Long COVID — surpassing Asthma as the most common chronic condition in kids today.

Want research updates like this in your inbox? Sign up at rthm.com

A new NIH RECOVER study followed hundreds of children under 6 & found that up to 15% met criteria for probable Long COVID. Distinct symptom patterns were seen by age group. Poor appetite, chronic cough, sleep issues, and fatigue were strongly linked to prior COVID-19 infection.